Costimulatory pathway targets for autoimmune and inflammatory conditions: clinical successes, failures, and hope for the future

Click to increase image sizeClick to decrease image size

Acknowledgments

The authors thank Gunilla Sturrock and Dorothy Shin for reviewing the article.

Declaration of interest

P Spicer and L Runkel are full-time employees at Informa. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose

Additional information

Funding

This paper was not funded.